H692Y

Category 3/4 — Most DruggableUncertain significanceLumenal · predictedσ-1 candidateSource card

Histidine → Tyrosine at position 692 · C-terminal ER-lumenal (calcium binding, calmodulin, chaperone) · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference

Wild-type H692 — hydrogen bond to L689

Fullscreen ↗

DynaMut2 mutant · H692Y

Mutant Y692 — hydrogen bond contact to L689 lost

Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

0 lost2 gained4 preserved

Interaction type	Wild-type partner	Mutant partner	Status
Hydrogen bond	L689	L689	Preserved
Hydrogen bond	—	E694	Gained
Polar contact	L689	L689	Preserved
Polar contact	C690	C690	Preserved
Polar contact	—	E694	Gained
Van der Waals	E694	E694	Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG

1.45kcal/mol

Stabilising — moderate

AlphaMissense

0.821

likely pathogenic

AlphaFold pLDDT

model confidence

Schema

Cat 3/4

Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance/Uncertain risk allele

Review statuscriteria provided, multiple submitters, no conflicts

Associated conditionsWolfram syndrome 1

Population frequency (gnomAD v4)Ultra-rare · AF 0.00099%

cDNA changec.2074C>T

ClinVar accessionVCV000429213

Last evaluated2024/06/24 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — H692Y Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Histidine → Tyrosine at position 692. C-terminal ER-lumenal (calcium binding. ClinVar Uncertain significance/Uncertain risk allele, AlphaMissense 0.821, DynaMut2 ΔΔG +1.45 kcal/mol (stabilising).

Identity

Field	Value
Variant	H692Y (p.Histidine692Tyrosine)
DNA change	c.2074C>T
Gene · Protein	WFS1 · Wolframin (890 aa)
UniProt	O76024 · WFS1_HUMAN
ClinVar accession	VCV000429213
Amino acid change	Histidine (H) → Tyrosine (Y)

Structural Context

Field	Value
AlphaFold model	AF-O76024-F1, v6
pLDDT at residue 692	88.06 — well-folded
Domain	C-terminal ER-lumenal (calcium binding, calmodulin, chaperone)
Position context	C-terminal lumenal domain · position 692 projects into the ER lumen
IDR flag	No — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 692 sits in the C-terminal lumenal domain (residues 653–869), wolframin's largest soluble region. This domain projects into the ER lumen and is implicated in calcium handling, ER stress sensing, and protein–protein interactions with ATF6 and Na+/K+ ATPase β1. The wild-type residue is titratable basic (histidine — imidazole); the mutant is aromatic with hydroxyl (tyrosine — H-bond donor/acceptor). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.

Computational Predictions

AlphaMissense

Field	Value
am_pathogenicity	0.8213
am_class	likely pathogenic
Interpretation	Likely pathogenic (threshold 0.564)

DynaMut2

Field	Value
ΔΔG (kcal/mol)	1.45 (Stabilising)
Job ID	178092147557
Result URL	https://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092147557

Clinical Evidence

Field	Value
Classification	Uncertain significance/Uncertain risk allele
Review status	criteria provided, multiple submitters, no conflicts
Last evaluated	2024/06/24 00:00
Inheritance	Autosomal recessive Wolfram syndrome 1 phenotype documented.
WFS1 variant landscape	H692Y is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

Wolfram syndrome 1

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=1.45 < 2 kcal/mol (fold intact) + AlphaMissense 0.821 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=1.45 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.821. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.

Files in this folder

AF-O76024-F1-model_v6.pdb — AlphaFold structure
H692Y_molstar_viewer.html — interactive 3D viewer (auto-highlights position 692 with ball-and-stick + neighbors within 5Å)
H692Y_variant_card.md — this card (source of truth)
H692Y_variant_card.html — styled printable card
H692Y_dynamut2_summary.html — clean offline DynaMut2 result card
dynamut2_result.json — structured result data
dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
H692Y_wildtype_interactions.pse / H692Y_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the H692Y PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download H692Y PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.